NZ568999A - Antimicrobial composition comprising EDTA and iodine or ionic silver - Google Patents

Antimicrobial composition comprising EDTA and iodine or ionic silver

Info

Publication number
NZ568999A
NZ568999A NZ568999A NZ56899906A NZ568999A NZ 568999 A NZ568999 A NZ 568999A NZ 568999 A NZ568999 A NZ 568999A NZ 56899906 A NZ56899906 A NZ 56899906A NZ 568999 A NZ568999 A NZ 568999A
Authority
NZ
New Zealand
Prior art keywords
composition
edta
iodine
ionic silver
weight
Prior art date
Application number
NZ568999A
Other languages
English (en)
Inventor
Steven L Percival
Phillip G Bowler
David Parsons
Original Assignee
Convatec Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Convatec Technologies Inc filed Critical Convatec Technologies Inc
Publication of NZ568999A publication Critical patent/NZ568999A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/12—Iodine, e.g. iodophors; Compounds thereof
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
    • A01N59/16—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0004—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A61L2300/104—Silver, e.g. silver sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/106—Halogens or compounds thereof, e.g. iodine, chlorite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/11—Peroxy compounds, peroxides, e.g. hydrogen peroxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/206—Biguanides, e.g. chlorohexidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/212—Peroxy acids, peracids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NZ568999A 2005-12-14 2006-12-14 Antimicrobial composition comprising EDTA and iodine or ionic silver NZ568999A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0525504.7A GB0525504D0 (en) 2005-12-14 2005-12-14 Antimicrobial composition
PCT/GB2006/004691 WO2007068938A2 (en) 2005-12-14 2006-12-14 Antimicrobial composition

Publications (1)

Publication Number Publication Date
NZ568999A true NZ568999A (en) 2011-12-22

Family

ID=35736154

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ568999A NZ568999A (en) 2005-12-14 2006-12-14 Antimicrobial composition comprising EDTA and iodine or ionic silver

Country Status (14)

Country Link
US (3) US9149035B2 (enExample)
EP (2) EP3241439B1 (enExample)
JP (4) JP5340741B2 (enExample)
CA (1) CA2632939C (enExample)
DK (1) DK1959739T3 (enExample)
ES (1) ES2622827T3 (enExample)
GB (1) GB0525504D0 (enExample)
HK (1) HK1246086A1 (enExample)
HU (1) HUE032810T2 (enExample)
LT (1) LT1959739T (enExample)
NZ (1) NZ568999A (enExample)
PL (1) PL1959739T3 (enExample)
PT (1) PT1959739T (enExample)
WO (1) WO2007068938A2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0525504D0 (en) * 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
DE102007030931A1 (de) * 2007-07-03 2009-01-08 Birgit Riesinger Zusammensetzung, enthaltend mindestens einen nutritiven, mindestens einen desinfizierenden bzw. dekontaminierenden und/oder mindestens einen Proteasen hemmend wirkenden Wirkstoff und/oder Wirkstoffkomplex
GB0714338D0 (en) * 2007-07-23 2007-09-05 Sinclair Pharmaceuticals Ltd method
EP2306821B1 (en) * 2008-05-30 2014-10-01 University Of Cincinnati Use of zinc chelators comprising dtpa to inhibit biofilm formation
US20100009009A1 (en) * 2008-07-10 2010-01-14 Micropure, Inc. Method and composition for prevention and treatment of oral fungal infections
US20100233101A1 (en) 2009-02-13 2010-09-16 Micropure, Inc. Composition and method for the oxidative consumption of salivary biomolecules
US8778387B2 (en) 2009-09-02 2014-07-15 Hyprotek, Inc. Antimicrobial medical dressings and protecting wounds and catheter sites
AU2011207398B2 (en) 2010-01-22 2014-11-20 Hyprotek, Inc. Antimicrobial agent comprising peroxide, alcohol and chelating agent
WO2011105869A2 (ko) * 2010-02-26 2011-09-01 주식회사 나이벡 치아의 접합능을 향상시키기 위한 치과용 클린저 조성물
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
GB201105829D0 (en) * 2011-04-06 2011-05-18 Convatec Technologies Inc Antimicrobial compositions
US8829053B2 (en) * 2011-12-07 2014-09-09 Rochal Industries Llp Biocidal compositions and methods of using the same
US10617472B2 (en) 2012-02-06 2020-04-14 Hyprotek, Inc. Adhesive patch with antimicrobial composition
WO2014100777A2 (en) * 2012-12-20 2014-06-26 Rajiv Bhushan Antimicrobial compositions
WO2014096843A2 (en) 2012-12-20 2014-06-26 Convatec Technologies Inc. Processing of chemically modified cellulosic fibres
ES2894839T3 (es) * 2013-03-07 2022-02-16 Kane Biotech Inc Composiciones antimicrobianas antibiopelícula que comprenden EDTA disódico y sodio
US10357470B2 (en) * 2013-03-07 2019-07-23 Kane Biotech Inc. Antimicrobial-antibiofilm compositions and methods of use thereof
GB201308770D0 (en) * 2013-05-15 2013-06-26 Convatec Technologies Inc Wound Dressing Comprising an Antimicrobial Composition
WO2015120458A1 (en) 2014-02-10 2015-08-13 Fred Hutchinson Cancer Research Center Halogen treatment of heart attack and ischemic injury
US20150272124A1 (en) * 2014-03-25 2015-10-01 Ecolab Usa Inc. Antimicrobial compositions containing cationic active ingredients
WO2016061299A1 (en) * 2014-10-15 2016-04-21 Biocide Pharma, Inc. Methods and apparatus for treating sites of infection
GB2533975A (en) * 2014-12-30 2016-07-13 Trio Healthcare Ltd Antibiofilm compositions
SE1650162A1 (en) * 2016-02-09 2017-08-10 Karladani Abbas Antimicrobial and cleansing composition comprising a polymeric biguanide, EDTA, and surfactants.
WO2017180879A1 (en) 2016-04-13 2017-10-19 Sage Products, Llc Chg compatible composition and method
GB201607814D0 (en) * 2016-05-04 2016-06-15 5D Health Prot Group Ltd Anti-microbial compositions
JP6456897B2 (ja) 2016-10-05 2019-01-23 マルハニチロ株式会社 抗菌性及び創傷治癒促進性を有する創傷治癒剤
RU2675628C2 (ru) * 2016-12-23 2018-12-21 Общество с ограниченной ответственностью "Технофарм" Композиция, содержащая протеинат серебра, и способ ее производства
CA3020197C (en) 2017-09-01 2024-06-04 Micropure, Inc. Aliphatic anionic compounds and oxidative compounds with improved stability and efficacy for use in pharmaceutical compositions
US11633434B2 (en) * 2017-09-07 2023-04-25 Technion Research & Development Foundation Limited Topical kits and compositions and use thereof
US11406525B2 (en) 2017-11-09 2022-08-09 11 Health And Technologies Limited Ostomy monitoring system and method
EP3801565A4 (en) * 2018-06-08 2022-04-06 Faraday Pharmaceuticals, Inc. USE OF HALOGENATED COMPOUNDS FOR THE TREATMENT AND PREVENTION OF TISSUE DAMAGE AND POST-INTENSIVE CARE SYNDROME
USD893514S1 (en) 2018-11-08 2020-08-18 11 Health And Technologies Limited Display screen or portion thereof with graphical user interface
CN113556939A (zh) 2018-12-27 2021-10-26 3M创新有限公司 具有1,2-链烷二醇的抗微生物组合物
EP4003012A1 (en) * 2019-07-29 2022-06-01 3M Innovative Properties Company Antimicrobial compositions and articles comprising the same
WO2022036264A1 (en) * 2020-08-13 2022-02-17 Tom Johnson Disinfectant compositions and methods of making and using the same
CN116829108A (zh) 2020-10-15 2023-09-29 康沃特克科技公司 造口术系统和方法
WO2022244013A1 (en) * 2021-05-21 2022-11-24 Prerna Goradia Light stable silver containing near neutral ph disinfectant and method of preparation
WO2024030261A1 (en) * 2022-08-04 2024-02-08 Seifert Kevin J Antimicrobial formulations and their methods for use

Family Cites Families (120)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2396514A (en) 1943-03-20 1946-03-12 Ludwig Jekels Sterilizing materials and methods for making the same
GB735462A (en) * 1951-12-20 1955-08-24 Dow Chemical Co Improvements in or relating to iodine-containing ethylenediaminetetraacetic acid compounds and methods of making same
US2785106A (en) 1952-08-16 1957-03-12 Ions Exchange And Chemical Cor Process for making antiseptic article
US3092552A (en) 1958-05-19 1963-06-04 Albert C Nolte Oligodynamic silver compositions and uses
US3061469A (en) 1959-11-05 1962-10-30 Givaudan Corp Antibacterial textile fabrics
US3246624A (en) 1965-02-05 1966-04-19 Novo Ind Corp Pressure indicating device
US4258056A (en) 1978-12-18 1981-03-24 Economics Laboratory, Inc. Control of mastitis and compositions therefor
JPS6015641B2 (ja) 1981-03-18 1985-04-20 花王株式会社 繊維状カルボキシメチルセルロ−スの製造方法
WO1984001721A1 (en) 1982-11-05 1984-05-10 Baxter Travenol Lab Antimicrobial compositions
US4655758A (en) 1982-12-16 1987-04-07 Johnson & Johnson Products, Inc. Microbial polysaccharide articles and methods of production
US4889654A (en) 1984-07-31 1989-12-26 Rio Linda Chemical Company, Inc. Aqueous foam disinfectant containing chlorine dixoide and preparation and use thereof
US4612337A (en) 1985-05-30 1986-09-16 The Trustees Of Columbia University In The City Of New York Method for preparing infection-resistant materials
US4728323A (en) 1986-07-24 1988-03-01 Minnesota Mining And Manufacturing Company Antimicrobial wound dressings
FR2604900B1 (fr) * 1986-10-08 1989-01-13 Blomet Marie Claude Solution physiologique pour le lavage des parties du corps humain ayant ete mises en contact avec un acide fluorhydrique et concentre pour sa preparation
GB8709498D0 (en) 1987-04-22 1987-05-28 Bay M Wound dressing
US4829129A (en) 1987-05-29 1989-05-09 International Dioxcide, Inc. Reaction product of polymer with chlorine dioxide
GB2220881B (en) 1988-04-28 1992-07-08 Toyo Boseki Improvements in or relating to superabsorbent materials
US4906100A (en) 1988-05-13 1990-03-06 University Of Cincinnati Method of detecting adriamycin (doxorubicin) or daunomycin in the environment
RU2092180C1 (ru) 1988-06-22 1997-10-10 Эпплаид Микробиолоджи Инк. Антимикробная композиция
US4973848A (en) 1989-07-28 1990-11-27 J. Mccaughan Laser apparatus for concurrent analysis and treatment
US5340924A (en) 1990-01-18 1994-08-23 Morinaga Milk Industry Co., Ltd. Method for heat treatment of lactoferrin without losing physiological activities thereof
US6066469A (en) 1990-03-08 2000-05-23 Ferro Dynamics, Inc. Cloning, expression, and uses of human lactoferrin
US5662913A (en) 1991-04-10 1997-09-02 Capelli; Christopher C. Antimicrobial compositions useful for medical applications
JPH06506694A (ja) 1991-04-10 1994-07-28 カペリ，クリストフアー・シー 医療用に有用な抗微生物組成物
GB9126193D0 (en) 1991-12-10 1992-02-12 Courtaulds Plc Cellulosic fibres
US5407656A (en) 1992-03-04 1995-04-18 Arco Research Co., Inc. Method and compositions for the production of chlorine dioxide
SK112494A3 (en) 1992-03-20 1995-04-12 Unilever Nv Aqueous cleaning composition
US5762620A (en) 1992-04-02 1998-06-09 Ndm Acquisition Corp. Wound dressing containing a partially dehydrated hydrogel
CA2140896A1 (en) 1992-07-22 1994-01-23 Kenneth Leslie Rabone Improvements in or relating to germicidal compositions
ATE239431T1 (de) 1992-10-21 2003-05-15 Gynetech Lab Inc Abgabesystem bestehend aus einem vaginaschwamm
WO1994016746A1 (en) 1993-01-22 1994-08-04 Courtaulds Plc Wound dressings
GB9301258D0 (en) 1993-01-22 1993-03-17 Courtaulds Plc Use of absorbent fibre
US5848995A (en) 1993-04-09 1998-12-15 Walder; Anthony J. Anti-infective medical article and method for its preparation
US5567495A (en) 1993-08-06 1996-10-22 The Trustees Of Columbia University In The City Of New York Infection resistant medical devices
US5744155A (en) 1993-08-13 1998-04-28 Friedman; Doron Bioadhesive emulsion preparations for enhanced drug delivery
JP3121503B2 (ja) 1994-10-18 2001-01-09 レンゴー株式会社 抗菌剤
JP3297969B2 (ja) 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
US5616347A (en) * 1995-02-14 1997-04-01 Alliger; Howard Chlorine dioxide skin medicating compositions for preventing irritation
CA2225808C (en) 1995-06-30 2002-12-17 Christopher C. Capelli Silver-based pharmaceutical compositions
SE506869C2 (sv) 1995-06-30 1998-02-23 Inst Polymerutveckling Ab Metod för laminering genom fotoympning, laminat framställt enligt metoden samt dess användning
DE19609143C1 (de) 1996-03-08 1997-11-13 Rhodia Ag Rhone Poulenc Melt-blown-Vlies, Verfahren zu dessen Herstellung und dessen Verwendungen
US5820918A (en) 1996-07-11 1998-10-13 Hercules Incorporated Medical devices containing in-situ generated medical compounds
AU735373B2 (en) 1996-08-16 2001-07-05 Christopher C. Capelli Silver-based antimicrobial compositions
US20030104018A1 (en) * 1996-12-31 2003-06-05 Griscom Bettle Skin product having micro-spheres, and processes for the production thereof
AU719928B2 (en) 1997-04-11 2000-05-18 Convatec Technologies Inc. Knitted wound dressings and method for making same
KR20010013377A (ko) 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US5993864A (en) * 1997-07-11 1999-11-30 Kross; Robert D. Chlorine dioxide chelate compositions and method of use
US5860947A (en) 1997-08-20 1999-01-19 Stamler; Keith D. Wound irrigation device and method
US6605751B1 (en) 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
US6753063B1 (en) 1997-11-19 2004-06-22 The Procter & Gamble Company Personal cleansing wipe articles having superior softness
IL123437A0 (en) 1998-02-24 1998-09-24 Shalev Pinchas Apparatus and method for photothermal destruction of oral bacteria
WO2000001425A1 (en) 1998-07-01 2000-01-13 Acordis Speciality Fibres Limited Wound dressings and materials suitable for use therein
US6413556B1 (en) 1999-01-08 2002-07-02 Sky High, Llc Aqueous anti-apoptotic compositions
DE19909214A1 (de) 1999-03-03 2000-09-07 Basf Ag Wasserabsorbierende, schaumförmige, vernetzte Polymerisate mit verbesserter Verteilungswirkung, Verfahren zu ihrer Herstellung und ihre Verwendung
GB9905663D0 (en) 1999-03-12 1999-05-05 Bristol Myers Squibb Co Iodine preparation composition
US6172040B1 (en) 1999-05-28 2001-01-09 A. Satyanarayan Naidu Immobilized lactoferrin antimicrobial agents and the use thereof
EP1216319B1 (en) 1999-09-27 2004-04-07 BHK Holding Ltd. Absorptive fabric
DE60040674D1 (de) 1999-10-01 2008-12-11 Acrymed Silber enthaltende zusammensetzungen, geräte und verfahren zu deren herstellung
US6592890B1 (en) 1999-10-20 2003-07-15 Oxibio, Inc. Conveyance of anti-infective activity to wound dressings
US6555508B1 (en) 2000-02-17 2003-04-29 Leonard Paul Liquid foaming soap compositions
AU2001239835A1 (en) 2000-02-26 2001-09-03 Advanced Photodynamic Technologies, Inc. Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant
AU2000265516A1 (en) 2000-08-11 2002-02-25 The Lawson Health Research Institute Compositions and methods for inhibiting islet dysfunction and autoimmune disorders
US20020091074A1 (en) * 2000-09-20 2002-07-11 Wooley Richard E. Medical compositions, dressings and methods for treating microbial infections of skin lesions
US20070003508A1 (en) * 2005-07-01 2007-01-04 Wooley Richard E Methods and compositions for promoting wound healing
GB2370226A (en) 2000-09-21 2002-06-26 Acordis Speciality Fibres Ltd Wound dressing
AU2002219937B9 (en) 2000-11-29 2006-03-16 Convatec Technologies Inc. Light stabilized antimicrobial materials
US20020172709A1 (en) 2001-03-30 2002-11-21 Brian Nielsen Medical dressing comprising an antimicrobial silver compound and a method for enhancing wound healing
ATE380041T1 (de) 2001-09-12 2007-12-15 Convatec Ltd Antibakterieller wundverband
GB2382527A (en) 2001-12-03 2003-06-04 Acordis Speciality Fibres Ltd Wound dressings
JP4165754B2 (ja) 2001-12-05 2008-10-15 タイコ・ヘルスケアー・グループ・エルピー 抗菌性システムおよび方法
US8541472B2 (en) * 2001-12-05 2013-09-24 Aseptica, Inc. Antiseptic compositions, methods and systems
SK3313U (sk) * 2002-02-11 2002-10-08 Unimed Pharma Spol Sro Očná instilácia na báze jódového aniónu
US6468965B1 (en) 2002-04-22 2002-10-22 Paul Cutler Pharmaceutical composition for oral administration of a mixture of chelating agents
GB0215023D0 (en) * 2002-06-28 2002-08-07 Bristol Myers Squibb Co Wound dressing
US20040033916A1 (en) 2002-06-28 2004-02-19 Kuzmin Vladimir Semenovich Disinfecting composition
US7311927B2 (en) * 2002-09-25 2007-12-25 Edwin Odell Miner Antiseptic solutions containing silver chelated with polypectate and EDTA
WO2004035718A2 (de) * 2002-10-14 2004-04-29 Arconia Gmbh Zusammensetzung
WO2004056346A1 (en) * 2002-12-19 2004-07-08 University Of Georgia Research Foundation, Inc. Methods and compositions for wound management
US7629000B2 (en) 2003-05-13 2009-12-08 E.I. Du Pont De Nemours And Company Method for making antimicrobial polyester-containing articles with improved wash durability and articles made thereby
CA2537059A1 (en) 2003-08-28 2005-05-12 Pure Bioscience Anhydrous silver dihydrogen citrate compositions
US20050059731A1 (en) 2003-09-16 2005-03-17 Ceramoptec Industries, Inc. Erythrosin-based antimicrobial photodynamic therapy compound and its use
US7033511B2 (en) 2004-01-20 2006-04-25 A-Dec, Inc. Sustained water treatment in dental equipment
EP1720411A1 (en) * 2004-02-24 2006-11-15 Campina B.V. Antimicrobial lactoferrin compositions for surfaces, cavities, and foodstuff
KR101226665B1 (ko) 2004-04-16 2013-01-25 브레덴트 메디칼 게엠베하 운트 코. 카게 미생물의 광역학적 제어를 위한 제제 및 상기 제제의 사용
KR20070061516A (ko) 2004-06-12 2007-06-13 시그넘바이오사이언스, 인코포레이티드 상피-관련 질환을 위한 국소용 조성물 및 방법
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
ATE410535T1 (de) 2004-07-09 2008-10-15 Johnson & Johnson Gmbh Kosmetischer und/oder dermatologischer absorbierender körperpflegeartikel mit mindestens einer absorbierenden schicht
CA2573744A1 (en) 2004-07-22 2006-03-02 Ondine International Ltd. Sonophotodynamic therapy for dental applications
CN101010004B (zh) 2004-07-30 2012-10-03 金伯利-克拉克环球有限公司 抗微生物的装置和组合物
US20060051430A1 (en) 2004-09-07 2006-03-09 Arata Andrew B Silver dihydrogen citrate compositions
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US20060115440A1 (en) 2004-09-07 2006-06-01 Arata Andrew B Silver dihydrogen citrate compositions
GB0424833D0 (en) 2004-11-10 2004-12-15 Photocure Asa Method
JP2008526997A (ja) 2005-01-14 2008-07-24 ニューロジェン・コーポレーション ヘテロアリール置換キノリン−４−イルアミン類縁体
US20060234959A1 (en) 2005-04-14 2006-10-19 Advanced Photodynamic Technologies, Inc. Photodynamic therapy utilizing multiple duty cycle light modulation
FR2884422B1 (fr) 2005-04-18 2008-04-11 Roquette Freres Composition anti-inflammatoire de l'intestin comprenant des maltodextrines branchees
US20060254988A1 (en) 2005-05-10 2006-11-16 Confirm Monitoring Systems, Inc. Methods and compositions for the treatment of water
GB0513552D0 (en) 2005-07-01 2005-08-10 Bristol Myers Squibb Co Bandage
JP3877174B1 (ja) 2005-09-13 2007-02-07 株式会社オーバル 弾性連結部材及び台座を有する三次モード振動の直管式コリオリ流量計
GB0525504D0 (en) 2005-12-14 2006-01-25 Bristol Myers Squibb Co Antimicrobial composition
JP2007167266A (ja) 2005-12-21 2007-07-05 Lion Corp 歯垢検出システムおよび歯垢検出方法
US20070166399A1 (en) 2006-01-13 2007-07-19 3M Innovative Properties Company Silver-containing antimicrobial articles and methods of manufacture
CA2646195C (en) 2006-04-11 2014-07-08 Tyco Healthcare Group Lp Wound dressings with anti-microbial and chelating agents
JP4826382B2 (ja) 2006-08-08 2011-11-30 アルケア株式会社 抗菌性セルロース繊維及び皮膚接触用繊維製品
EP1925719B1 (en) 2006-09-21 2011-11-09 Alcare Co., Ltd. Antibacterial fiber, method for production of the fiber, antibacterial fiber product comprising the antibacterial fiber, method for production of the product, and method for regeneration of the product
US9034352B2 (en) 2006-11-14 2015-05-19 Rohm And Haas Company Microbicide combinations containing silver
WO2008088922A2 (en) 2007-01-19 2008-07-24 Genentech, Inc. Prevention of hydrogel viscosity loss
GB0710846D0 (en) 2007-06-06 2007-07-18 Bristol Myers Squibb Co A wound dressing
GB0805162D0 (en) 2008-03-19 2008-04-23 Bristol Myers Squibb Co Antibacterial wound dressing
US20100015245A1 (en) 2008-04-24 2010-01-21 Joe Harrison Combination of Copper Cations with Peroxides or Quaternary Ammonium Compounds for the Treatment of Biofilms
CA2724973C (en) 2008-05-20 2015-08-11 University Health Network Device and method for fluorescence-based imaging and monitoring
US9221963B2 (en) 2008-11-27 2015-12-29 Speciality Fibres And Materials Ltd. Absorbent material
GB0823265D0 (en) 2008-12-20 2009-01-28 Convatec Technologies Inc Antimicrobial Composition
US20100310845A1 (en) 2009-06-03 2010-12-09 Eric Bryan Bond Fluid permeable structured fibrous web
GB2474694B (en) 2009-10-23 2011-11-02 Innovia Films Ltd Biodegradable composites
US20110237994A1 (en) 2010-03-25 2011-09-29 Combat Medical Systems, Llc Void-filling wound dressing
CA2816311C (en) 2010-11-01 2018-07-17 Becton, Dickinson And Company Gardnerella vaginalis assay
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
GB201105829D0 (en) 2011-04-06 2011-05-18 Convatec Technologies Inc Antimicrobial compositions
GB201308770D0 (en) 2013-05-15 2013-06-26 Convatec Technologies Inc Wound Dressing Comprising an Antimicrobial Composition

Also Published As

Publication number Publication date
ES2622827T3 (es) 2017-07-07
PL1959739T3 (pl) 2017-07-31
US20070190176A1 (en) 2007-08-16
US20150306055A1 (en) 2015-10-29
US9149035B2 (en) 2015-10-06
LT1959739T (lt) 2017-04-25
CA2632939A1 (en) 2007-06-21
JP2009519312A (ja) 2009-05-14
DK1959739T3 (en) 2017-05-01
AU2006325408A1 (en) 2007-06-21
EP3241439A1 (en) 2017-11-08
PT1959739T (pt) 2017-04-24
WO2007068938A3 (en) 2008-09-18
JP2013209385A (ja) 2013-10-10
JP6509948B2 (ja) 2019-05-08
EP1959739A2 (en) 2008-08-27
EP3241439B1 (en) 2020-12-02
US10493101B2 (en) 2019-12-03
JP2017214386A (ja) 2017-12-07
US9545390B2 (en) 2017-01-17
WO2007068938A2 (en) 2007-06-21
JP5340741B2 (ja) 2013-11-13
JP6348892B2 (ja) 2018-06-27
GB0525504D0 (en) 2006-01-25
HUE032810T2 (en) 2017-11-28
EP1959739B1 (en) 2017-03-29
HK1246086A1 (en) 2018-09-07
JP2016040294A (ja) 2016-03-24
CA2632939C (en) 2016-06-07
US20170079276A1 (en) 2017-03-23

Similar Documents

Publication Publication Date Title
US10493101B2 (en) Antimicrobial composition
Percival et al. Antiseptics for treating infected wounds: efficacy on biofilms and effect of pH
AU2012238401B2 (en) Composition comprising antimicrobial metal ions and a quaternary cationic surfactant
Lee et al. Effects of Epigallocatechin gallate against Enterococcus faecalis biofilm and virulence
Ortega‐Peña et al. In vitro microbicidal, anti‐biofilm and cytotoxic effects of different commercial antiseptics
Gmur et al. Povidone-iodine in wound healing and prevention of wound infections
AU2013206810B2 (en) Antimicrobial composition
AU2006325408B2 (en) Antimicrobial composition
EP1545490A1 (en) Fosfomycin and n-acetylcysteine for the treatment of biofilms caused by escheric ia coli and other pathogens of the urinary tract
Roberts Antimicrobial agents used in wound care
Finotelli et al. Microbiological and toxicity analyses of the synthetic polymer polyhexamethylene guanidine hydrochloride against endodontic microorganisms
TR201808398A2 (tr) Biyofilm Üretiminin Engellenmesi ve Eradikasyonunda Yeni Kombine Kullanım

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: CONVATEC TECHNOLOGIES, INC., US

Free format text: OLD OWNER(S): BRISTOL-MYERS SQUIBB COMPANY

PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 14 DEC 2016 BY CPA GLOBAL

Effective date: 20131101

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2017 BY CPA GLOBAL

Effective date: 20161029

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2018 BY CPA GLOBAL

Effective date: 20171102

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2019 BY CPA GLOBAL

Effective date: 20181102

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2020 BY CPA GLOBAL

Effective date: 20191031

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 14 DEC 2021 BY CPA GLOBAL

Effective date: 20201030

LAPS Patent lapsed